Mathematical Foundations of Artificial Intelligence
Machine Learning and Artificial Intelligence (AI) are enabling extraordinary scientific breakthroughs in fields ranging from protein folding, natural language processing, drug synthesis, and recommender systems to the discovery of novel engineering materials and products. Offered by U.S. National Science Foundation; awards $500K – $1.5M; applications due October 9, 2026.
Key Facts
- Funder
- U.S. National Science Foundation
- Award amount
- $500K – $1.5M
- Deadline
- October 9, 2026
- Geography
- United States
- Categories
- Technology
- Status
- Open
About This Grant
Machine Learning and Artificial Intelligence (AI) are enabling extraordinary scientific breakthroughs in fields ranging from protein folding, natural language processing, drug synthesis, and recommender systems to the discovery of novel engineering materials and products. These achievements lie at the confluence of mathematics, statistics, engineering and computer science, yet a clear explanation of the remarkable power and also the limitations of such AI systems has eluded scientists from all...
Full requirements and application instructions: official listing.
Similar Open Grants
Unlocking Dataset Value for AI-Enabled Scientific Discovery
U.S. National Science Foundation
Engineering Research Initiation
U.S. National Science Foundation
Collaboratory to Advance Mathematics Education and Learning (CAMEL) for K-12
U.S. National Science Foundation
Professional Formation of Engineers
U.S. National Science Foundation
Engineering Biological and Biomedical Systems (EBBS)
U.S. National Science Foundation
Transport Phenomena (TP)
U.S. National Science Foundation
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health